^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Meta10-19
i
Other names: Meta10-19, metabolically armed CD19 CAR-T, Meta1019, Meta 10-19
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Leman Biotech
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
18d
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research (clinicaltrials.gov)
P1, N=36, Recruiting, Zhejiang University
New P1 trial • CAR T-Cell Therapy
|
cyclophosphamide • Meta10-19
20d
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research (clinicaltrials.gov)
P1, N=36, Recruiting, Zhejiang University
New P1 trial • CAR T-Cell Therapy
|
cyclophosphamide • Meta10-19
8ms
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research (clinicaltrials.gov)
P1, N=36, Recruiting, The Children's Hospital of Zhejiang University School of Medicine
New P1 trial • CAR T-Cell Therapy
|
cyclophosphamide • Meta10-19
10ms
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research (clinicaltrials.gov)
P1, N=18, Recruiting, Anhui Provincial Hospital
New P1 trial
|
cyclophosphamide • Meta10-19
1year
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research (clinicaltrials.gov)
P1, N=18, Recruiting, He Huang
New P1 trial • CAR T-Cell Therapy
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • BCL2 (B-cell CLL/lymphoma 2) • CD19 (CD19 Molecule) • BCL6 (B-cell CLL/lymphoma 6) • IL6 (Interleukin 6)
|
CD19 expression • BCL2 translocation
|
cyclophosphamide • Meta10-19
almost2years
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research (clinicaltrials.gov)
P1, N=18, Recruiting, Anhui Provincial Hospital
New P1 trial • CAR T-Cell Therapy
|
CD19 (CD19 Molecule)
|
CD19 expression
|
cyclophosphamide • Meta10-19
almost2years
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research (clinicaltrials.gov)
P1, N=18, Recruiting, Anhui Provincial Hospital | Not yet recruiting --> Recruiting
Enrollment open • CAR T-Cell Therapy
|
CD19 (CD19 Molecule)
|
CD19 expression
|
cyclophosphamide • Meta10-19
almost2years
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research (clinicaltrials.gov)
P1, N=18, Not yet recruiting, Anhui Provincial Hospital
New P1 trial • CAR T-Cell Therapy
|
CD19 (CD19 Molecule)
|
CD19 expression
|
cyclophosphamide • Meta10-19
Share via
